• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (55)
    • Structure and absolute configuration of karlotoxin-2, an ichthyotoxin from the marine dinoflagellate Karlodinium veneficum.
    • Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction.
    • The role of perceived threat in the emergence of PTSD and depression symptoms during warzone deployment.
    • National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
    • Platelet plasminogen activator inhibitor 1 in patients with type II diabetes.
    • See All 55 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Platelet plasminogen activator inhibitor 1 in patients with type II diabetes.

Platelet plasminogen activator inhibitor 1 in patients with type II diabetes. Diabetes Care. 1994 Aug; 17(8):818-23.

View in: PubMed

subject areas
  • beta-Thromboglobulin
  • Blood Platelets
  • Blood Pressure
  • Cholesterol
  • C-Peptide
  • Diabetes Mellitus, Type 2
  • Diet, Diabetic
  • Female
  • Humans
  • Hypoglycemic Agents
  • In Vitro Techniques
  • Male
  • Middle Aged
  • Plasminogen Activator Inhibitor 1
  • Platelet Aggregation
  • Platelet Factor 4
  • Reference Values
  • Triglycerides

authors with profiles
  • Maria F Lopes-Virella
  • John A. Colwell